Indication
Human Papillomavirus Type 16
1 clinical trial
1 product
Clinical trial
A Phase I Open Label, Dose Escalation Clinical Trial Assessing the Safety, Tolerability, and Feasibility of pNGVL4aCRTE6E7L2 HPV DNA Vaccine Administration Via Intramuscular TriGridTM Electroporation Delivery System to Patients With HPV16-Positive High-Grade Cervical Intraepithelial NeoplasiaStatus: Recruiting, Estimated PCD: 2024-09-30
Product
pNGVL4aCRTE6E7L2